Description
The global endoscopy sterilization market was valued at USD 1.2 billion in 2025 and is projected to reach USD 1.9 billion by 2032, expanding at a CAGR of 6.8% from 2026 to 2032. Endoscopy sterilization encompasses the processes, equipment, and consumable solutions used to eliminate microorganisms, including bacteria, viruses, fungi, and spores, from endoscopic instruments before they are reused in medical procedures. The market covers devices and consumables & accessories, with applications spanning hospitals, ambulatory surgical centers, and other healthcare settings where endoscopic equipment must undergo rigorous cleaning, disinfection, sterilization, drying, storage, and reprocessing. These solutions are critical to reducing the risk of healthcare-associated infections (HAIs), preventing cross-contamination, and maintaining patient safety during diagnostic and therapeutic procedures. The growing use of gastrointestinal, pulmonary, urological, orthopedic, and other minimally invasive endoscopic interventions is expanding the need for reliable and efficient sterilization workflows. As healthcare providers perform higher volumes of procedures, the ability to rapidly reprocess endoscopes while maintaining stringent infection control standards has become increasingly important. This is strengthening demand for automated endoscope reprocessors, advanced sterilization systems, drying and storage technologies, and recurring consumables used throughout the reprocessing cycle.
Market expansion is being supported by the rising incidence of HAIs, increasing endoscopic procedure volumes, stricter infection prevention requirements, and continued investment in hospital sterile processing infrastructure. Technological advancement is also reshaping the industry, with healthcare facilities increasingly adopting low-temperature sterilization approaches such as hydrogen peroxide and ozone-based technologies that can effectively process heat-sensitive endoscopic instruments while supporting faster turnaround times. The growing integration of automated endoscope reprocessors (AERs), standardized reprocessing protocols, monitoring systems, and improved drying and storage solutions is further strengthening operational efficiency and infection control. At the same time, the adoption of single-use endoscopes and disposable components is emerging as an important complementary trend, particularly in high-throughput clinical environments where reducing reprocessing complexity and cross-contamination risks is a priority. North America currently represents the largest regional market, supported by high procedure volumes and stringent sterilization and reprocessing requirements, while Asia Pacific is positioned as the fastest-growing regional market as healthcare infrastructure expands and endoscopic services become more accessible. Over the forecast period, the market is expected to evolve toward more automated, low-temperature, integrated, and digitally monitored reprocessing ecosystems, with emerging healthcare markets creating additional opportunities for advanced sterilization technologies.
Key Highlights of the Report
• In terms of product, Devices dominate the global endoscopy sterilization market, driven by the increasing adoption of automated endoscope reprocessors, advanced sterilization equipment, and specialized drying, storage, and transport systems designed to improve reprocessing efficiency and minimize contamination risks.
• The Devices segment remains the core equipment category within the market, supported by continued investments in hospital sterile processing infrastructure and the need for reliable sterilization workflows across gastroenterology, pulmonology, urology, and other endoscopy-intensive specialties.
• The Consumables & Accessories segment is projected to record the fastest growth, supported by the recurring requirement for disinfectants, detergents, enzymatic cleaners, test strips, sterilization indicators, and other products required during routine endoscope reprocessing cycles.
• Based on sterilization method, Hydrogen Peroxide Sterilization dominates the global endoscopy sterilization market, driven by its suitability for heat-sensitive endoscopic instruments, low-temperature operating conditions, effective microbial control, and ability to support faster turnaround in high-volume clinical environments.
• The Ethylene Oxide (EtO) Sterilization segment continues to maintain a significant position, supported by its ability to sterilize heat- and moisture-sensitive devices, penetrate complex instrument geometries, and process a broad range of medical device materials.
• The Liquid Chemical Sterilization segment is gaining traction, supported by relatively short processing times, compatibility with automated endoscope reprocessors, and its suitability for high-level disinfection of flexible endoscopes in hospitals and specialized endoscopy centers.
• By end use, Hospitals dominate the global endoscopy sterilization market, reflecting their high volume of diagnostic and therapeutic procedures and the need to maintain continuous availability of sterile equipment for multiple departments and back-to-back procedures.
• The Ambulatory Surgical Centers segment is projected to record strong growth, supported by the migration of minimally invasive procedures toward outpatient settings, shorter patient stays, cost-efficiency considerations, and the expansion of specialized endoscopy facilities.
• The market is increasingly shifting toward automated reprocessing workflows, as healthcare providers seek to reduce manual intervention, improve process consistency, shorten equipment turnaround times, and strengthen compliance with infection prevention protocols.
• Low-temperature sterilization technologies are emerging as a key technology trend, particularly for delicate endoscopic equipment that may be vulnerable to high temperatures or moisture associated with conventional sterilization methods.
• The growing use of single-use endoscopes and disposable components is influencing market dynamics, as healthcare facilities look for ways to reduce the complexity of reprocessing and lower the potential risk of infection transmission in high-demand clinical settings.
• North America dominates the global endoscopy sterilization market, primarily driven by a high volume of diagnostic and therapeutic endoscopic procedures, stringent infection control requirements, established healthcare infrastructure, and regulatory emphasis on validated sterilization and reprocessing practices.
• Asia Pacific is projected to be the fastest-growing regional market, supported by the expanding healthcare infrastructure, increasing endoscopic procedure volumes, growing burden of gastrointestinal diseases, medical tourism, and rising adoption of advanced infection control technologies.
• The competitive landscape is moderately concentrated, with STERIS leading the market, supported by its broad infection prevention portfolio, automated endoscope reprocessing capabilities, sterilization systems, disinfectants, and integrated workflow solutions.
• The market is characterized by competition across global and regional manufacturers, with companies differentiating themselves through product innovation, sterilization efficiency, regulatory compliance, global distribution capabilities, and integrated reprocessing solutions.
• The key growth drivers include the rising incidence of healthcare-associated infections, increasing endoscopic procedure volumes, technological advances in sterilization equipment, and greater investments in healthcare infrastructure and sterile processing departments.
• High capital costs associated with advanced sterilization systems and the complexity of endoscope reprocessing remain key market challenges, particularly for healthcare facilities that must maintain strict protocols, specialized infrastructure, and trained personnel.
• Emerging opportunities are centered on automated sterilization and reprocessing technologies, integrated drying and storage systems, low-temperature sterilization solutions, and expanding healthcare infrastructure in emerging economies where endoscopic services are increasing.
• The market is expected to increasingly favor integrated infection control ecosystems, combining automated reprocessing, sterilization, monitoring, drying, storage, and traceability capabilities to improve workflow efficiency and support consistent compliance with infection prevention standards.
Key Company Profiles
• ARC Healthcare Solutions
• ASP
• AURORA
• ECOLAB
• HUMAN MEDITEK
• MMM Group
• Olympus
• Richard Wolf
• Steelco
• STERIS
• Stryker
Data Source
Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise.
